Home/Filings/4/0001209191-23-031655
4//SEC Filing

Hillan Kenneth J. 4

Accession 0001209191-23-031655

CIK 0001804591other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:05 PM ET

Size

5.4 KB

Accession

0001209191-23-031655

Insider Transaction Report

Form 4
Period: 2023-05-20
Hillan Kenneth
Head of Therapeutics
Transactions
  • Tax Payment

    Class A Common Stock

    2023-05-20$1.94/sh4,628$8,978192,842 total
Footnotes (2)
  • [F1]The closing price on May 19, 2023, the fair market value used for the transaction date.
  • [F2]Includes 5,765 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on February 28, 2023.

Issuer

23andMe Holding Co.

CIK 0001804591

Entity typeother

Related Parties

1
  • filerCIK 0001600359

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:05 PM ET
Size
5.4 KB